These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17845399)

  • 1. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
    Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
    Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
    Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
    Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
    Kanekura T; Kawahara K; Maruyama I; Kanzaki T
    Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytapheresis treatment for pyoderma gangrenosum.
    Fujimoto E; Fujimoto N; Kuroda K; Tajima S
    Br J Dermatol; 2004 Nov; 151(5):1090-2. PubMed ID: 15541092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyoderma gangrenosum: case series].
    Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
    Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.
    Toyozawa S; Yamamoto Y; Nishide T; Kishioka A; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
    Dermatol Online J; 2008 Nov; 14(11):17. PubMed ID: 19094855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum--a review.
    Wollina U
    Orphanet J Rare Dis; 2007 Apr; 2():19. PubMed ID: 17433111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of peristomal pyoderma gangrenosum.
    Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
    Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyoderma gangrenosum: a report of 3 cases].
    Ma ZL; Zhang TL
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1479-81. PubMed ID: 18275714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease.
    Hanafusa T; Azukizawa H; Umegaki N; Tani M; Yamaguchi Y; Katayama I
    J Dermatol; 2011 May; 38(5):507-10. PubMed ID: 21352279
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.
    Holt PJ; Davies MG; Saunders KC; Nuki G
    Medicine (Baltimore); 1980 Mar; 59(2):114-33. PubMed ID: 7360040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
    Fukunaga K; Fukuda Y; Sawada K; Hori K; Matoba Y; Sagayama K; Ohnishi K; Fukui S; Shimoyama T
    J Gastroenterol; 2003; 38(7):684-9. PubMed ID: 12898362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum--case report.
    Abela CB; Soldin M; Gateley D
    Br J Oral Maxillofac Surg; 2007 Jun; 45(4):328-30. PubMed ID: 16360244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.
    Rogge FJ; Pacifico M; Kang N
    J Plast Reconstr Aesthet Surg; 2008; 61(4):431-3. PubMed ID: 18358433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.
    Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A
    Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.